Hormone responses to fenfluramine and placebo challenge in endogenous depression

1992 ◽  
Vol 43 (2) ◽  
pp. 137-146 ◽  
Author(s):  
Pesach Lichtenberg ◽  
Baruch Shapira ◽  
Dan Gillon ◽  
Seth Kindler ◽  
Thomas B. Cooper ◽  
...  
1984 ◽  
Vol 144 (6) ◽  
pp. 636-639 ◽  
Author(s):  
T. H. Corn ◽  
A. S. Hale ◽  
C. Thompson ◽  
P. K. Bridges ◽  
S. A. Checkley

SummaryThe growth hormone responses to clonidine (1.3 μg/kgm) and apomorphine (0.005 mg/kgm) have been measured in 8 drug free patients with endogenous depression. In these patients the growth hormone responses to clonidine were significantly smaller than to apomorphine. As these doses of clonidine and apomorphine have previously been reported to cause similar growth hormone responses in normal subjects, these findings support the hypothesis of a defect in the adrenergic but not the dopaminergic regulation of growth hormone in patients with endogenous depression.


1979 ◽  
Vol 9 (1) ◽  
pp. 107-115 ◽  
Author(s):  
S. A. Checkley

SYNOPSISIt is suggested that, if depressed patients have deficient noradrenergic function at central α-adrenergic receptors, then they will also have impaired corticosteroid responses to methylamphetamine but unaltered growth hormone responses. This prediction has been confirmed when the responses of a group of patients with endogenous depression were compared with the responses of a group of patients with other functional psychoses, a group of patients with reactive depression, and a group of patients with other psychiatric diagnoses. These findings support the hypothesis that there is a functional deficiency of noradrenaline at some central α-adrenergic receptors.


2009 ◽  
Vol 42 (05) ◽  
Author(s):  
P Netter ◽  
C Toll ◽  
A Siegmund ◽  
T Birkenbach-Holdschuh ◽  
C Lujic

1974 ◽  
Vol 75 (3) ◽  
pp. 497-502
Author(s):  
Mayer B. Davidson ◽  
Roger M. Steele

ABSTRACT Since fructose is normally metabolized in diabetics and has recently been shown to stimulate GH secretion, it was used to assess GH responses in diabetics. Fourteen diabetics (9 on insulin) and 8 controls matched for weight were studied. Fructose, infused over 10 min, was compared to arginine, infused over 30 min, both at 0.5 g/kg. Samples were collected at 0, 30, 60, 90 and 120 min and GH responses assessed as area under the curve minus the fasting area. There was no significant difference between the GH responses in diabetics and controls to either agent. Responses to arginine and fructose were significantly correlated (r = 0.60, P < 0.01) in all subjects, but not related to therapy, duration of disease or fasting glucose (75–287 mg/100 ml) in the diabetics. Oral glucose blunted the GH response to fructose in 2 controls. It is concluded that 1) fructose can stimulate GH secretion in male diabetics; 2) however, fructose-stimulated GH responses are not increased in diabetes mellitus.


Diabetes ◽  
1987 ◽  
Vol 36 (4) ◽  
pp. 518-522 ◽  
Author(s):  
S. A. Amiel ◽  
D. C. Simonson ◽  
W. V. Tamborlane ◽  
R. A. DeFronzo ◽  
R. S. Sherwin
Keyword(s):  

1990 ◽  
Vol 5 (1) ◽  
pp. 29-30
Author(s):  
F Lang ◽  
J Pellet ◽  
B Estour

SummaryThe authors report the case of a 45-yr-old male who presented from 1979 to 1986 with several severe depressive episodes. The patient fulfilled Feighner criteria for major depression, Newcastle criteria for endogenous depression: the depressive episodes were all classified as severe recurrent depression without melancholia according to DSM III. The patient was resistant to different types of treatment (ECT, tricyclic and MAOI drugs, lithium, sleep deprivation). With a treatment of 10 cg/day of fenetyline, reduced to 5 cg/day after 6 months, (atypical manic episode), the patient improved considerably for 20 rnonths. The therapeutic response decreased after this period but after a month of withdrawal, the patient again responded. The authors cannot explain the duration of this therapeutic response.


Sign in / Sign up

Export Citation Format

Share Document